Cannabis Use and Epigenetic Changes: Emerging Scientific Insights

Cannabis Use and Epigenetic Changes: Emerging Scientific Insights

Cannabis, one of the most widely used psychoactive substances globally, has garnered significant attention in recent years due to its legalization in various regions and its potential therapeutic applications. However, alongside its growing acceptance, concerns about its long-term effects on human health, particularly at the molecular level, have prompted rigorous scientific investigation. Recent research has revealed that cannabis use is associated with epigenetic changes—modifications to gene expression that do not involve alterations to the underlying DNA sequence. These findings have profound implications for understanding the biological impact of cannabis use and its potential intergenerational effects. This essay explores the evidence linking cannabis use to epigenetic changes, the mechanisms involved, and the broader implications for public health, drawing on recent scientific literature. Epigenetic Modifications: A Brief Overview Epigenetics refers to heritable changes in gene expression that occur without altering the DNA sequence itself. These changes are mediated by mechanisms such as DNA methylation, histone modification, and non-coding RNA regulation, which collectively influence how genes are activated or silenced (Moore et al., 2013). DNA methylation, in particular, involves the addition of methyl groups to cytosine bases in DNA, often suppressing gene expression. Epigenetic modifications are dynamic, influenced by environmental factors such as diet, stress, and substance use, including cannabis (Feinberg, 2018). Given cannabis’s psychoactive properties and its interaction with the endocannabinoid system, researchers have hypothesized that its use could induce epigenetic changes with lasting effects on cellular function and health. Evidence Linking Cannabis Use to Epigenetic Changes Recent studies have provided compelling evidence that cannabis use is associated with alterations in DNA methylation patterns. A landmark study by Schrott et al. (2021) investigated the epigenetic effects of cannabis use in humans and animal models, focusing on DNA methylation in sperm. The researchers found that cannabis users exhibited significant differences in DNA methylation at multiple genomic loci compared to non-users. These changes were particularly pronounced in genes related to neurodevelopment and immune function, suggesting that cannabis use may influence biological processes critical to brain health and immune response (Schrott et al., 2021). Furthermore, the study identified similar methylation patterns in the sperm of rats exposed to tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, indicating a potential conservation of epigenetic effects across species. Another study by Osborne et al. (2020) explored the impact of cannabis use on epigenetic aging, a measure of biological age derived from DNA methylation patterns. The researchers found that chronic cannabis users exhibited accelerated epigenetic aging compared to non-users, as measured by the Horvath epigenetic clock (Osborne et al., 2020). This finding suggests that cannabis use may contribute to premature cellular aging, potentially increasing the risk of age-related diseases. While the precise mechanisms underlying these changes remain under investigation, the interaction between THC and cannabinoid receptors in the brain and peripheral tissues is thought to play a central role in modulating epigenetic processes (DiNieri et al., 2011). Mechanisms of Cannabis-Induced Epigenetic Changes The endocannabinoid system, which includes cannabinoid receptors (CB1 and CB2), is a key mediator of cannabis’s physiological effects. THC binds to CB1 receptors in the brain, altering neurotransmitter release and influencing gene expression through downstream signaling pathways (Pertwee, 2008). These pathways, including the mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) cascades, can modulate epigenetic machinery, such as DNA methyltransferases and histone deacetylases (D’Addario et al., 2013). For instance, chronic THC exposure has been shown to alter histone acetylation in the hippocampus, a brain region critical for memory and learning, potentially contributing to cognitive impairments observed in long-term cannabis users (Prini et al., 2018). Moreover, cannabis use may induce oxidative stress and inflammation, both of which are known to influence epigenetic modifications (Feinberg, 2018). Oxidative stress can disrupt DNA methylation by altering the availability of methyl donors, such as S-adenosylmethionine (SAM), while inflammation may upregulate enzymes that modify histone proteins (Moore et al., 2013). These molecular changes provide a plausible mechanism by which cannabis use could lead to persistent epigenetic alterations, potentially affecting not only the user but also their offspring through transgenerational epigenetic inheritance (Schrott et al., 2021). Implications for Public Health and Future Research The discovery of cannabis-associated epigenetic changes raises important considerations for public health, particularly in the context of increasing cannabis legalization and use. Epigenetic modifications in sperm, as observed by Schrott et al. (2021), suggest that cannabis use may have intergenerational effects, potentially influencing the health and development of offspring. For example, altered methylation in neurodevelopmental genes could increase the risk of neurodevelopmental disorders in children of cannabis users, a hypothesis that warrants further investigation. Similarly, the accelerated epigenetic aging reported by Osborne et al. (2020) underscores the need to assess the long-term health risks of chronic cannabis use, particularly in relation to cardiovascular and neurodegenerative diseases. Despite these findings, significant gaps in knowledge remain. The reversibility of cannabis-induced epigenetic changes, the dose-response relationship, and the impact of different cannabis constituents (e.g., THC vs. cannabidiol) are areas that require further exploration. Longitudinal studies are needed to determine whether these epigenetic changes persist after cessation of cannabis use and to elucidate their clinical significance. Additionally, research should investigate the role of environmental and lifestyle factors, such as diet and stress, in modulating cannabis-related epigenetic effects. Conclusion Emerging evidence suggests that cannabis use is linked to epigenetic changes, particularly in DNA methylation patterns, with potential implications for neurodevelopment, immune function, and biological aging. These findings highlight the complex interplay between cannabis, the endocannabinoid system, and epigenetic regulation, underscoring the need for caution in the context of widespread cannabis use. While current research provides valuable insights, further studies are essential to fully understand the scope and reversibility of these epigenetic changes and their impact on individual and public health. As cannabis legalization continues to expand, integrating these scientific findings into public health policy and education will be critical to promoting informed decision-making and mitigating potential risks.

### References D’Addario, C., DiNieri, J. A., & Hurd, Y. L. (2013). Epigenetic regulation of gene expression in the brain by drugs of abuse. *Neuropsychopharmacology*, 38(1), 167–183. https://doi.org/10.1038/npp.2012.167 DiNieri, J. A., Wang, X., Szutorisz, H., Spano, S. M., Kaur, J., Casaccia, P., ... & Hurd, Y. L. (2011). Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. *Biological Psychiatry*, 70(8), 763–769. https://doi.org/10.1016/j.biopsych.2011.06.007 Feinberg, A. P. (2018). The key role of epigenetics in human disease prevention and mitigation. *New England Journal of Medicine*, 378(14), 1323–1334. https://doi.org/10.1056/NEJMra1402513 Moore, L. D., Le, T., & Fan, G. (2013). DNA methylation and its basic function. *Neuropsychopharmacology*, 38(1), 23–38. https://doi.org/10.1038/npp.2012.112 Osborne, A. J., Pearson, J. F., Noble, A. J., Gemmell, N. J., & Horwood, L. J. (2020). Cannabis use and epigenetic aging: Evidence from the Christchurch Health and Development Study. *Drug and Alcohol Dependence*, 216, 108228. https://doi.org/10.1016/j.drugalcdep.2020.108228 Pertwee, R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. *British Journal of Pharmacology*, 153(2), 199–215. https://doi.org/10.1038/sj.bjp.0707442 Prini, P., Rusconi, F., Zamberletti, E., Gabaglio, M., Penna, F., Fasano, M., ... & Rubino, T. (2018). Adolescent THC exposure causes enduring prefrontal cortical disruption of GABAergic inhibition and dysregulation of sub-cortical dopamine function. *Scientific Reports*, 8(1), 1–13. https://doi.org/10.1038/s41598-018-34329-4 Schrott, R., Acharya, K., Iturra-Mena, A. M., Diwadkar, A., Hurd, Y. L., & Murphy, S. K. (2021). Cannabis use is associated with differential methylation in human sperm. *Epigenetics*, 16(7), 757–767. https://doi.org/10.1080/15592294.2020.1827722

Cannabis Use Is Linked to Epigenetic Changes, Scientists Discover